X0206 3 2015-02-04 0 0001618561 Nexvet Biopharma plc NVET 0001632454 McCracken Joseph S C/O NEXVET BIOPHARMA PLC NATL INST, FOSTERS AVENUE, MOUNT MERRION BLACKROCK L2 00000 IRELAND 1 0 0 0 Ordinary Shares 2400 D Restricted Share Units 0.125 2015-03-31 2019-07-01 Ordinary Shares 1800 D Restricted Share Units 0.125 2015-03-31 2019-07-01 Ordinary Shares 5000 D 50% of the Restricted Share Units shall vest and become convertible on 3/31/15, and the remaining 50% shall vest on 6/30/15, in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting. 500 of the Restricted Share Units shall vest and become convertible on each of 3/31/15, 6/30/15, 9/30/15, 12/31/15, 3/31/16, 6/30/16, 9/30/16, 12/31/16, 3/31/17 and 6/30/17, in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting. /s/ Joseph S. McCracken by Damian Lismore, Attorney-in-Fact 2015-02-04